Ovesen, Christian
Jakobsen, Janus Christian
Gluud, Christian
Steiner, Thorsten
Law, Zhe
Flaherty, Katie
Dineen, Rob A.
Bath, Philip M.
Sprigg, Nikola
Christensen, Hanne
Clinical trials referenced in this document:
Documents that mention this clinical trial
Effects of blood pressure and tranexamic acid in spontaneous intracerebral haemorrhage: a secondary analysis of a large randomised controlled trial
https://doi.org/10.1136/bmjno-2023-000423
Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT (Results)
https://doi.org/10.3310/hta23350
Does tranexamic acid lead to changes in MRI measures of brain tissue health in patients with spontaneous intracerebral haemorrhage? Protocol for a MRI substudy nested within the double-blind randomised controlled TICH-2 trial
https://doi.org/10.1136/bmjopen-2017-019930
Prevention of haematoma progression by tranexamic acid in intracerebral haemorrhage patients with and without spot sign on admission scan: a statistical analysis plan of a pre-specified sub-study of the TICH-2 trial
https://doi.org/10.1186/s13104-018-3481-8
Funding for this research was provided by:
National Institute for Health Research (project number 11_129_109)
Swiss Heart Foundation
Velux Fonden (grant no. 00012779)
Bispebjerg Hospital
Københavns Universitet
Danish Medical Association
Axel Muusfeldts Fond
Article History
Received: 24 January 2018
Accepted: 5 June 2018
First Online: 13 June 2018